Teva Pharma (TEVA) Launches Generic of Minastrin 24 Fe in U.S.
ADMIN
0
5,647
2017.03.21 00:07
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced the launch of the Authorized Generic of Minastrin® 24 Fe1 (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) 1 mg/20 mcg in the U.S.
The Authorized Generic of Minastrin® 24 Fe is an estrogen/progestin combined oral contraceptive indicated for use by women to prevent pregnancy.
The Authorized Generic of Minastrin® 24 Fe is an estrogen/progestin combined oral contraceptive indicated for use by women to prevent pregnancy.